BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25192974)

  • 1. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
    Stefanetti G; Rondini S; Lanzilao L; Saul A; MacLennan CA; Micoli F
    Vaccine; 2014 Oct; 32(46):6122-9. PubMed ID: 25192974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
    PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on Sugar-Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines.
    De Benedetto G; Salvini L; Gotta S; Cescutti P; Micoli F
    Bioconjug Chem; 2018 May; 29(5):1736-1747. PubMed ID: 29697244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines.
    Stefanetti G; Hu QY; Usera A; Robinson Z; Allan M; Singh A; Imase H; Cobb J; Zhai H; Quinn D; Lei M; Saul A; Adamo R; MacLennan CA; Micoli F
    Angew Chem Int Ed Engl; 2015 Nov; 54(45):13198-203. PubMed ID: 26350581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
    Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Click Chemistry Applied to the Synthesis of Salmonella Typhimurium O-Antigen Glycoconjugate Vaccine on Solid Phase with Sugar Recycling.
    Stefanetti G; Saul A; MacLennan CA; Micoli F
    Bioconjug Chem; 2015 Dec; 26(12):2507-13. PubMed ID: 26549104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.
    Simon R; Wang JY; Boyd MA; Tulapurkar ME; Ramachandran G; Tennant SM; Pasetti M; Galen JE; Levine MM
    PLoS One; 2013; 8(5):e64680. PubMed ID: 23741368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.
    Baliban SM; Yang M; Ramachandran G; Curtis B; Shridhar S; Laufer RS; Wang JY; Van Druff J; Higginson EE; Hegerle N; Varney KM; Galen JE; Tennant SM; Lees A; MacKerell AD; Levine MM; Simon R
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005493. PubMed ID: 28388624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM
    Stefanetti G; Allan M; Usera A; Micoli F
    Glycoconj J; 2020 Oct; 37(5):611-622. PubMed ID: 32535667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F
    Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy against
    Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R
    Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constructing conjugate vaccine against Salmonella Typhimurium using lipid-A free lipopolysaccharide.
    Chiu TW; Peng CJ; Chen MC; Hsu MH; Liang YH; Chiu CH; Fang JM; Lee YC
    J Biomed Sci; 2020 Aug; 27(1):89. PubMed ID: 32831077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens.
    Rondini S; Lanzilao L; Necchi F; O'Shaughnessy CM; Micoli F; Saul A; MacLennan CA
    Microb Pathog; 2013 Oct; 63():19-23. PubMed ID: 23756206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
    Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Salmonella Typhimurium core oligosaccharide and its reducing end 3-deoxy-d-manno-oct-2-ulosonic acid used for conjugate vaccine production.
    De Benedetto G; Micoli F; Londero S; Salvini L; Sturiale L; Garozzo D; Ravenscroft N; Giannelli C; Cescutti P
    Carbohydr Res; 2019 Jul; 481():43-51. PubMed ID: 31228656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of O-polysaccharide chains extracted from different Salmonella Typhimurium strains.
    Micoli F; Ravenscroft N; Cescutti P; Stefanetti G; Londero S; Rondini S; Maclennan CA
    Carbohydr Res; 2014 Feb; 385():1-8. PubMed ID: 24384528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O:2-CRM(197) conjugates against Salmonella Paratyphi A.
    Micoli F; Rondini S; Gavini M; Lanzilao L; Medaglini D; Saul A; Martin LB
    PLoS One; 2012; 7(11):e47039. PubMed ID: 23144798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-Antigen Extraction, Purification, and Chemical Conjugation to a Carrier Protein.
    Micoli F; Giannelli C; Di Benedetto R
    Methods Mol Biol; 2021; 2183():267-304. PubMed ID: 32959249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.
    Nilo A; Passalacqua I; Fabbrini M; Allan M; Usera A; Carboni F; Brogioni B; Pezzicoli A; Cobb J; Romano MR; Margarit I; Hu QY; Berti F; Adamo R
    Bioconjug Chem; 2015 Aug; 26(8):1839-49. PubMed ID: 26230938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.